Biomakers of Brain Ageing

A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Molecular and Cellular Neuroscience".

Deadline for manuscript submissions: closed (20 April 2020) | Viewed by 15474

Special Issue Editor


E-Mail Website
Guest Editor
Laboratoty Physiology Department Translational Medicine, UPO, Via Solaroli 17, 28100 Novara, Italy
Interests: cell biology; ageing; nutraceuticals; neurogical disorders; natural extract; molecular biology; 3D in vitro models; gut-brain axis; gut-eye axis; gut-prostate axis; ADME in vitro model
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Aging is a physiological process which includes changes at all levels of the biological organization that are counterbalanced by adaptive response mechanisms produced to preserve the composition and function within homeostatic balance. The aging process produces a deterioration of different patterns of body structure and functions, but the most critical compartment involved is brain, where a dysfunction can lead to neural disability. This deterioration is the primary risk factor for major human pathologies, including cancer, diabetes, cardiovascular disorders, and neurodegenerative diseases. The functional decline associated with normal brain aging is mostly associated with genomic instability, telomere attrition, epigenetic alterations, loss of protein homeostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, and stem cell exhaustion causing neurodegenerative disorders. Therefore, an aging brain in good health is in any case characterized by decline in neuronal activity and loss of synaptic connection and function. In this context, some interventions can slow down physiological and pathological progression through their antioxidant, anti-inflammatory, and antiamyloidogenic properties, regulating mitochondrial stress, apoptotic factors, free radical scavenging system, and neurotrophic factors. For example, the use of nutraceutical molecules (such as vitamin D3, ginger, and lipoic acid) is known to exert beneficial effects on the brain. Indeed, some phytomolecules, like polyphenols, are able to cross the blood–brain barrier (BBB) and act with a protective role against oxidative stress and autophagic pathways and can modulate apoptosis and survival pathways of neurons. On the other hand, the brain-derived neurotrophic factor (BDNF) can be considered as a marker for the development, maintenance, and plasticity of the central and peripheral nervous systems. BDNF promotes the differentiation of neurons from stem cells, and it can prevent programmed cell death/apoptosis. Moreover, emerging findings suggest that BDNF is a master regulator of energetic homeostasis. Natural products and synthetic drugs could stimulate BDNF production, or activate its receptor TrkB, to prevent and treat metabolic and brain disorders connected with aging.

Even if aging is a physiological problem, recent findings suggest that age-related neurodegenerative disorders could be slowed down; it is, therefore, important to continue to pursue novel approaches for the implementation of new compounds able to make old age less debilitating.

Dr. Francesca Uberti
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Neurotrophic factors
  • Brain aging
  • Food supplements
  • Neuronal molecular pathways

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

20 pages, 2150 KiB  
Article
A New Palmitoylethanolamide Form Combined with Antioxidant Molecules to Improve Its Effectivess on Neuronal Aging
by Vera Morsanuto, Rebecca Galla, Claudio Molinari and Francesca Uberti
Brain Sci. 2020, 10(7), 457; https://0-doi-org.brum.beds.ac.uk/10.3390/brainsci10070457 - 17 Jul 2020
Cited by 16 | Viewed by 3965
Abstract
Palmitoylethanolamide is a nutraceutical compound naturally produced in many plants and animal source foods, but the natural form is poorly water-soluble. It has demonstrated an anti-inflammatory role as a neuroprotective mediator, acting on several molecular targets of the central nervous system involved on [...] Read more.
Palmitoylethanolamide is a nutraceutical compound naturally produced in many plants and animal source foods, but the natural form is poorly water-soluble. It has demonstrated an anti-inflammatory role as a neuroprotective mediator, acting on several molecular targets of the central nervous system involved on brain aging process. In healthy adults, palmitoylethanolamide is an endogenous PPAR-α (peroxisome proliferator-activated receptor α) agonist through which it performs anti-inflammatory activity and provides its effects by activating the cannabinoid receptor. The different formulations of palmitoylethanolamide (micronized palmitoylethanolamide, FM-LipoMatrix® palmitoylethanolamide and FM-LipoMatrix® palmitoylethanolamide plus lipoic acid and vitamin D3) were analyzed starting from intestinal barrier, to verify their bioavailability, to in primary astrocytes in which cell viability, reactive oxygen species (ROS) and nitric oxide (NO) production, NFKB activity, MAPK, p53 and PPARα activities were investigated. Additionally, cannabinoid and estrogen receptors were analyzed using the western blot technique. The combination of palmitoylethanolamide in FM-LipoMatrix®, lipoic acid and vitamin D3 shows better absorption predicting an improvement on plasma concentration; this formulation also shows a reduction in ROS and NO production and the data show the interaction of palmitoylethanolamide with cannabinoids and estrogen receptors inhibiting neuroinflammatory markers. All these data support the hypothesis of a new potential strategy to restore brain function and slow down brain aging in humans. Full article
(This article belongs to the Special Issue Biomakers of Brain Ageing)
Show Figures

Figure 1

29 pages, 3604 KiB  
Article
The Role of BDNF on Aging-Modulation Markers
by Claudio Molinari, Vera Morsanuto, Sara Ruga, Felice Notte, Mahitab Farghali, Rebecca Galla and Francesca Uberti
Brain Sci. 2020, 10(5), 285; https://0-doi-org.brum.beds.ac.uk/10.3390/brainsci10050285 - 09 May 2020
Cited by 35 | Viewed by 4927
Abstract
An important link between brain aging and a class of growth/survival factors called neurotrophins has recently been demonstrated. In particular, brain-derived neurotrophic factor (BDNF) plays a fundamental role during age-related synaptic loss, preventing cerebral atrophy and cognitive decline. The aim of the present [...] Read more.
An important link between brain aging and a class of growth/survival factors called neurotrophins has recently been demonstrated. In particular, brain-derived neurotrophic factor (BDNF) plays a fundamental role during age-related synaptic loss, preventing cerebral atrophy and cognitive decline. The aim of the present study was to investigate whether the use of low dose BDNF sequentially kinetic activated (SKA) was able to counteract some mechanisms underlying the degeneration and aging of nervous tissue by increasing endogenous protection mechanisms. Both in vitro and in vivo experiments were performed to assess the ability of BDNF SKA to protect and regenerate survival-related molecular pathways, studying intestinal absorption in vitro and brain function in vivo. Our pioneering results show that BDNF SKA is able to induce the endogenous production of BDNF, using its receptor TrkB and influencing the apolipoprotein E expression. Moreover, BDNF SKA exerted effects on β-Amyloid and Sirtuin 1 proteins, confirming the hypothesis of a fine endogenous regulatory effect exerted by BDNF SKA in maintaining the health of both neurons and astrocytes. For this reason, a change in BDNF turnover is considered as a positive factor against brain aging. Full article
(This article belongs to the Special Issue Biomakers of Brain Ageing)
Show Figures

Graphical abstract

Review

Jump to: Research

21 pages, 952 KiB  
Review
Can Brain Health Be Supported by Vitamin D-Based Supplements? A Critical Review
by Mahitab Farghali, Sara Ruga, Vera Morsanuto and Francesca Uberti
Brain Sci. 2020, 10(9), 660; https://0-doi-org.brum.beds.ac.uk/10.3390/brainsci10090660 - 22 Sep 2020
Cited by 20 | Viewed by 6161
Abstract
This review presents recent knowledge on the neuroprotective effects of vitamin D and their usefulness as oral supplementation when combined with other molecules, such as curcumin. A critical look at the effectiveness of vitamin D in this field is also provided. Vitamin D [...] Read more.
This review presents recent knowledge on the neuroprotective effects of vitamin D and their usefulness as oral supplementation when combined with other molecules, such as curcumin. A critical look at the effectiveness of vitamin D in this field is also provided. Vitamin D plays a crucial role in neuroprotection and in the cognitive decline associated with aging, where vitamin D’s levels are related to the levels of several neurotrophic factors. An important role of vitamin D has also been observed in the mechanism of neuroinflammation, which is the basis of several aging conditions, including cognitive decline and neurodegeration; furthermore, the neuroprotective effect of vitamin D in the cognitive decline of aging has recently been reported. For this reason, many food supplements created for humans contain vitamin D alone or combined with other molecules with antioxidant properties. However, recent studies also explored negative consequences of the use at a high dosage of vitamin D. Vitamin D in tissues or brain cells can also modulate calbindin-D28K, parvalbumin, and calretinin, and is involved in immune function, thanks also to the combination with curcumin. Curcumin acts as a free radical scavenger and antioxidant, inhibiting lipid peroxidation and oxidative DNA damage. In particular, curcumin is a potent immune-regulatory agent and its administration has been reported to attenuate cognitive impairments. These effects could be exploited in the future to control the mechanisms that lead to the brain decay typical of neurodegenerative diseases. Full article
(This article belongs to the Special Issue Biomakers of Brain Ageing)
Show Figures

Figure 1

Back to TopTop